The Madison Investors Fund (class I) decreased 0.4% in the fourth quarter of 2024, compared to the 2.4% increase in the S&P ...

Cigna's strong growth potential, Evernorth expansion, and stock buybacks make it undervalued. Click here to find out why CI ...

Elevance Health says its acquisition of Verily’s Granular Insurance is designed to bolster its offerings to self-funded ...

All participants will be in listen-only mode. [Operator instructions] After today's presentation, there will be an ...

INDIANAPOLIS (AP) — INDIANAPOLIS (AP) — Elevance Health Inc. (ELV) on Thursday reported fourth-quarter net income of $418 million. The Indianapolis-based company said it had net income of $1. ...

The oncology testing specialist reported strong top-line growth, but also rising costs and ongoing net losses.

Reports Q4 revenue $646.5M, consensus $650.9M. Seth Blackley, Co-Founder and Chief Executive Officer of Evolent stated, “Evolent delivered ...

In the fourth quarter of 2024, BB Biotech shares posted a total return of -2.7% in CHF and -3.5% in EUR. NAV performance improved, rising by 2.7% in CHF and 2.8% in EUR, though it declined by 4.3% in ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The stock’s fifty day moving average price is C$19.26. Invesco S&P Emerging Markets Low Volatility Index ETF has a twelve ...

Healthcare solutions company Evolent Health (NYSE:EVH) in Q4 CY2024, but sales rose 16.3% year on year to $646.5 million.